Affordable Access

Publisher Website

Receptor-mediated radiopharmaceuticals

Authors
Journal
Trends in Pharmacological Sciences
0165-6147
Publisher
Elsevier
Publication Date
Volume
5
Identifiers
DOI: 10.1016/0165-6147(84)90367-5
Disciplines
  • Design
  • Medicine
  • Pharmacology

Abstract

Abstract The development of radiotracers with defined affinities for specific receptor systems is a potentially useful approach to the design of radiopharmaceuticals for nuclear medicine. Radiolabelled ligands, such as hormones and neurotransmitters, are being synthesized and evaluated as diagnostic tools for diseases which can be characterized either by changes in receptor concentration or by novel receptor expression. Since the utility of a radiopharmaceutical is dependent upon the achievement of adequate ratios of target to nontarget accumulation of radioactivity, design of radiotracers via the receptor approach attempts to exploit those systems in which receptor is present in significantly higher concentration at potential target sites such as tumors. Receptor-mediated radiotracers are also currently being used in animal models to investigate the normal tissue distribution of drug and hormone receptors and the in-vivo pharmacokinetics of receptor binding. The successful development of receptor-avid radiopharmaceuticals will depend on the ability to synthesize ligands of high specific radioactivity which retain the high affinity and binding specificity for the receptor after radiolabelling.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

Radiopharmaceuticals for receptor imaging.

on Journal of Nuclear Medicine May 1983

Fluorine-18 labeled receptor based radiopharmaceut...

on International journal of radia... 1986

[New radiopharmaceuticals and imaging of the heart...

on Giornale italiano di cardiolog... August 1991
More articles like this..